Material matter: Korean marketing approval sought for CTP51, a Keytruda biosimilar
DART
Celltrion, Inc.
Filed Aug 24, 2026 KST · Filing
· receipt 20260824800001
kstock has not written this one up.
The title above is a translation of the Korean form name; the filing itself is on DART, in
Korean.
Read the original on DART ↗Korean. DART is Korea's electronic disclosure system, run by the Financial Supervisory
Service — the filing equivalent of EDGAR.
Korean form name: 투자판단관련주요경영사항 (CTP51(키트루다 바이오시밀러) 한국 품목허가 신청)